Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

Dempsey A, Cohn L, Dalton V, Ruffin M.

Vaccine. 2010 Jan 22;28(4):989-95. doi: 10.1016/j.vaccine.2009.10.133. Epub 2009 Nov 17.

2.

Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization.

Chao C, Velicer C, Slezak JM, Jacobsen SJ.

Mayo Clin Proc. 2009 Oct;84(10):864-70. doi: 10.1016/S0025-6196(11)60503-X.

3.

Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study.

Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, Hambidge SJ, Jacobsen SJ, Klein NP, Naleway AL, Zangwill KM, Jackson LA.

Am J Public Health. 2009 Oct;99 Suppl 2:S389-97. doi: 10.2105/AJPH.2008.151332.

4.

Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination.

Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA.

J Womens Health (Larchmt). 2009 Oct;18(10):1679-86. doi: 10.1089/jwh.2008.1329.

PMID:
19785564
5.

National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):997-1001.

6.

Factors associated with completion of the human papillomavirus vaccine series.

Neubrand TP, Breitkopf CR, Rupp R, Breitkopf D, Rosenthal SL.

Clin Pediatr (Phila). 2009 Nov;48(9):966-9. doi: 10.1177/0009922809337534. Epub 2009 May 29. No abstract available.

PMID:
19483128
7.

Preventive care for adolescents: few get visits and fewer get services.

Irwin CE Jr, Adams SH, Park MJ, Newacheck PW.

Pediatrics. 2009 Apr;123(4):e565-72. doi: 10.1542/peds.2008-2601.

PMID:
19336348
8.

Disparities in how parents are learning about the human papillomavirus vaccine.

Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):363-72. doi: 10.1158/1055-9965.EPI-08-0418. Epub 2009 Feb 3.

9.

Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women.

Cates JR, Brewer NT, Fazekas KI, Mitchell CE, Smith JS.

J Rural Health. 2009 Winter;25(1):93-7. doi: 10.1111/j.1748-0361.2009.00204.x.

PMID:
19166567
10.

Adolescent vaccination: recommendations from the National Vaccine Advisory Committee.

National Vaccine Advisory Committee., Stokley S, Freed G, Curtis R, Gordon L, Humiston S, Parnell T, Pavia A, Young A, Johnson D, Kennedy A, Hopfensperger D, Markowitz L, Fergie J, Koslap-Petraco MB, McCauley M.

Am J Prev Med. 2009 Mar;36(3):278-9.e6. doi: 10.1016/j.amepre.2008.10.015. Epub 2009 Jan 21. No abstract available.

PMID:
19162432
11.

National health surveys and the behavioral model of health services use.

Andersen RM.

Med Care. 2008 Jul;46(7):647-53. doi: 10.1097/MLR.0b013e31817a835d.

PMID:
18580382
12.

How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents?

Schaffer SJ, Fontanesi J, Rickert D, Grabenstein JD, Rothholz MC, Wang SA, Fishbein D; Working Group on Complementary Settings..

Pediatrics. 2008 Jan;121 Suppl 1:S35-45. doi: 10.1542/peds.2007-1115E.

PMID:
18174319
13.

Delivering adolescent vaccinations in the medical home: a new era?

Szilagyi PG, Rand CM, McLaurin J, Tan L, Britto M, Francis A, Dunne E, Rickert D; Working Group on Adolescent Vaccination in the Medical Home..

Pediatrics. 2008 Jan;121 Suppl 1:S15-24. doi: 10.1542/peds.2007-1115C. Review.

PMID:
18174317
14.

Timing of hepatitis B vaccination: its effect on vaccine response in health care workers.

Sabidó M, Gavaldà L, Olona N, Ramon JM.

Vaccine. 2007 Oct 23;25(43):7568-72. Epub 2007 Sep 4.

PMID:
17870215
16.

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.

Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J.

Lancet. 2007 May 19;369(9574):1693-702.

PMID:
17512854
17.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators..

N Engl J Med. 2007 May 10;356(19):1928-43.

18.

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.

FUTURE II Study Group..

N Engl J Med. 2007 May 10;356(19):1915-27.

19.

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

Reisinger KS, Block SL, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, Puchalski D, Giacoletti KE, Sings HL, Lukac S, Alvarez FB, Barr E.

Pediatr Infect Dis J. 2007 Mar;26(3):201-9.

PMID:
17484215
20.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC).; Advisory Committee on Immunization Practices (ACIP)..

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

Supplemental Content

Support Center